The high incidence of drug-resistant epilepsy in DYNC1H1-related cases might be associated with the manifestation of MCD, which are observed in up to 92% of patients with DYNC1H1-related epilepsy.[7] The drug-resistant nature of DYNC1H1-related epilepsy poses significant therapeutic challenges. Here, DYNC1H1 is linked to epilepsy.